Dr. Milana Frenkel-Morgenstern
Our research strategy aims to identify unique potential drug targets in cancer cells. The drug targets we are looking for are abnormal fusion transcripts, also known as “chimeric RNAs,” that can be shown to exist only, or predominantly, in various cancer cells.  Our BioComputing Lab has at its disposal 4 Dell PowerEdge 820 servers, each containing 32 cores and 1 TB of RAM. The system is connected to 1PetaByte storage.
 Genome research cover page 2012
Our lab website: biodb.md.biu.ac.il/mmorgensternlab/